AI Liability: What Healthcare Investors Must Do Now
The world of healthcare investing is being rocked by AI, but not just with promises of big returns. A new threat is here: algorithmic liability.…
Algorithmic Bias in Healthcare: A Billion-Dollar Blind Spot
We keep hearing that AI will fix healthcare by optimizing resources, finding at-risk patients, and making workflows simpler. But as more AI tools get adopted,…
Automated Prior Authorization: Unseen Risks for Payers and Investors
Algorithms meant to speed up insurance approvals are instead blocking patients from getting necessary care, creating huge operational and legal headaches for payers. We’re tracking…
FDA Generative AI: De-Risking Your CDS Investment
Get your AI tool’s regulatory pathway wrong, and you can delay your market launch by years. What was a promising innovation becomes a regulatory nightmare.…
Sepsis AI: The Billion Dollar Cost of False Positives
The hype around AI in healthcare promises precision medicine and simplified care, but the on-the-ground reality is often a mess, especially when an algorithm isn’t…
AI Recalls: Investing Lessons from SaMD’s Past Failures
Generative AI in healthcare is coming with huge risks. For digital health investors and regulatory compliance officers, the question isn’t if these sophisticated algorithms will…
AI’s Shadow: How Diagnostic AI Erodes Resident Training
The push for AI in medical diagnostics promises speed and precision, but it’s casting a serious shadow over how we train doctors. If we let…
Olive AI: The Billion Dollar Bust Built on Zero Evidence
The promise of artificial intelligence in healthcare often conjures images of precision diagnostics, optimized workflows, and ultimately, improved patient outcomes. Yet, the meteoric rise and…
Babylon Health: The Billion Dollar AI Safety Failure
The spectacular collapse of Babylon Health, once valued at $4.2 billion, serves as a stark reminder that in healthcare AI, investment durability hinges not on…
Healthcare AI Graveyard: Why Evidence, Not Hype, Drives Value
The healthcare AI landscape, brimming with transformative potential, also serves as a stark graveyard for ventures that prioritized hype over evidence. From the spectacular implosion…